Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	short-chain fatty acid transmembrane transporter activity	SLC22A9 SLC22A10	1.01e-04	5	64	2	GO:0015636
GeneOntologyBiologicalProcess	negative regulation of type II interferon production	HLA-DRB1 ZNF683 CR1 PDCD1LG2	2.01e-05	51	65	4	GO:0032689
GeneOntologyBiologicalProcess	T cell differentiation	EOMES FZD8 STK11 JMJD6 HLA-DRB1 AMBRA1 ZNF683 CR1	2.58e-05	382	65	8	GO:0030217
GeneOntologyBiologicalProcess	T cell activation	EOMES FZD8 STK11 JMJD6 HLA-DRB1 AMBRA1 ZNF683 CR1 RAC2 PDCD1LG2	6.38e-05	701	65	10	GO:0042110
Domain	PKD	PKD1L1 PMEL	2.48e-04	7	65	2	PF00801
Domain	PKD/Chitinase_dom	PKD1L1 PMEL	4.23e-04	9	65	2	IPR022409
Domain	PKD	PKD1L1 PMEL	4.23e-04	9	65	2	SM00089
Domain	PKD	PKD1L1 PMEL	6.43e-04	11	65	2	PS50093
Domain	PKD_dom	PKD1L1 PMEL	6.43e-04	11	65	2	IPR000601
Domain	-	PKD1L1 PMEL	6.43e-04	11	65	2	2.60.40.670
Domain	RHO	RAC2 RAC3	2.18e-03	20	65	2	PS51420
Domain	zf-C2H2	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	2.69e-03	693	65	8	PF00096
Domain	ZINC_FINGER_C2H2_2	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	5.29e-03	775	65	8	PS50157
Domain	ZINC_FINGER_C2H2_1	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	5.37e-03	777	65	8	PS00028
Domain	Znf_C2H2	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	6.62e-03	805	65	8	IPR007087
Domain	ZnF_C2H2	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	6.76e-03	808	65	8	SM00355
Pubmed	A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.	HLA-DRB1 IRF5	3.66e-06	2	67	2	18408250
Pubmed	B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb.	RGMB PDCD1LG2	3.66e-06	2	67	2	28479601
Pubmed	Structure and chromosomal assignment to 22q12 and 17qter of the ras-related Rac2 and Rac3 human genes.	RAC2 RAC3	3.66e-06	2	67	2	9299243
Pubmed	RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance.	RGMB PDCD1LG2	3.66e-06	2	67	2	24752301
Pubmed	Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.	HLA-DRB1 HIC2 IRF5	5.46e-06	18	67	3	19838193
Pubmed	Identification of a novel murine organic anion transporter like protein 1 (OATLP1) expressed in the kidney.	SLC22A9 SLC22A10	1.10e-05	3	67	2	17079864
Pubmed	Characterization of mouse organic anion transporter 5 as a renal steroid sulfate transporter.	SLC22A9 SLC22A10	1.10e-05	3	67	2	16150593
Pubmed	Isoform-specific membrane targeting mechanism of Rac during Fc gamma R-mediated phagocytosis: positive charge-dependent and independent targeting mechanism of Rac to the phagosome.	RAC2 RAC3	1.10e-05	3	67	2	16081809
Pubmed	Signaling and cytoskeletal requirements in erythroblast enucleation.	RAC2 RAC3	1.10e-05	3	67	2	22461493
Pubmed	Renal expression of organic anion transporter Oat5 in rats and mice exhibits the female-dominant sex differences.	SLC22A9 SLC22A10	1.10e-05	3	67	2	20865662
Pubmed	Identification of a novel organic anion transporter mediating carnitine transport in mouse liver and kidney.	SLC22A9 SLC22A10	1.10e-05	3	67	2	20332632
Pubmed	rac, a novel ras-related family of proteins that are botulinum toxin substrates.	RAC2 RAC3	1.10e-05	3	67	2	2674130
Pubmed	Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.	RAC2 RAC3	1.10e-05	3	67	2	22123845
Pubmed	HLA-DRB1, IRF5, and CD28 gene polymorphisms in Egyptian patients with rheumatoid arthritis: susceptibility and disease activity.	HLA-DRB1 IRF5	1.10e-05	3	67	2	34017081
Pubmed	Pathophysiological Mechanisms in Neurodevelopmental Disorders Caused by Rac GTPases Dysregulation: What's behind Neuro-RACopathies.	RAC2 RAC3	1.10e-05	3	67	2	34943902
Pubmed	Distinct Roles of Small GTPases Rac1 and Rac2 in Histamine H4 Receptor-Mediated Chemotaxis of Mast Cells.	HRH4 RAC2	1.10e-05	3	67	2	30021868
Pubmed	Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members.	SLC22A9 SLC22A10	2.19e-05	4	67	2	19417012
Pubmed	Isolation of a family of organic anion transporters from human liver and kidney.	SLC22A9 SLC22A10	2.19e-05	4	67	2	11327718
Pubmed	Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney.	SLC22A9 SLC22A10	2.19e-05	4	67	2	15068970
Pubmed	Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.	EOMES ZNF683	3.64e-05	5	67	2	34462601
Pubmed	Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis.	EOMES ZNF683	3.64e-05	5	67	2	34183415
Pubmed	PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase.	RAC2 RAC3	3.64e-05	5	67	2	22043008
Pubmed	Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1.	HLA-DRB1 IRF5	7.63e-05	7	67	2	20797713
Pubmed	ILC1 Confer Early Host Protection at Initial Sites of Viral Infection.	EOMES ZNF683	7.63e-05	7	67	2	29056343
Pubmed	The yin-yang of PR-domain family genes in tumorigenesis.	PRDM7 PRDM5	7.63e-05	7	67	2	10668202
Pubmed	FoxO6 affects Plxna4-mediated neuronal migration during mouse cortical development.	EOMES PLXNA4	7.63e-05	7	67	2	27791111
Pubmed	A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation.	SPRY4 CBL	7.63e-05	7	67	2	16893902
Pubmed	Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.	EOMES ZNF683	1.02e-04	8	67	2	31810881
Pubmed	Generation and characterization of Rac3 knockout mice.	RAC2 RAC3	1.02e-04	8	67	2	15964829
Pubmed	AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.	EOMES AMBRA1	1.02e-04	8	67	2	33854232
Pubmed	Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task.	RAC2 RAC3	1.02e-04	8	67	2	24598074
Pubmed	RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.	FZD8 RNF43	1.02e-04	8	67	2	31286874
Pubmed	SET domains and histone methylation.	PRDM7 PRDM5	1.02e-04	8	67	2	14675547
Pubmed	CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.	RAC2 RAC3	1.02e-04	8	67	2	27048830
Pubmed	Developmental nonlinearity drives phenotypic robustness.	SPRY4 RICTOR	1.63e-04	10	67	2	29213092
Pubmed	Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates.	SPRY4 CBL	1.63e-04	10	67	2	18273061
Pubmed	Regulation of lymphatic-blood vessel separation by endothelial Rac1.	RAC2 RAC3	1.63e-04	10	67	2	19906871
Pubmed	ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.	FZD8 RNF43	1.99e-04	11	67	2	22575959
Pubmed	The human formin FHOD1 contains a bipartite structure of FH3 and GTPase-binding domains required for activation.	RAC2 RAC3	1.99e-04	11	67	2	18786395
Pubmed	Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.	SPRY4 CBL	2.38e-04	12	67	2	17974561
Pubmed	Molecular physiology of renal organic anion transporters.	SLC22A9 SLC22A10	2.81e-04	13	67	2	16403838
Pubmed	CbGRiTS: cerebellar gene regulation in time and space.	EOMES PCSK9	2.81e-04	13	67	2	25446528
Pubmed	Plexin signaling via off-track and rho family GTPases.	PLXNA4 RAC2	2.81e-04	13	67	2	11604131
Pubmed	Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa.	SLC22A9 SLC22A10	2.81e-04	13	67	2	15369770
Pubmed	Elf5 and Ets2 maintain the mouse extraembryonic ectoderm in a dosage dependent synergistic manner.	EOMES SPRY4	3.28e-04	14	67	2	25446535
Pubmed	Genome-wide association study of pancreatic cancer in Japanese population.	RNF149 RNF43	3.28e-04	14	67	2	20686608
Pubmed	Essential role of Rac1 and Rac3 GTPases in neuronal development.	RAC2 RAC3	3.28e-04	14	67	2	19126596
Pubmed	Multiple roles for Nodal in the epiblast of the mouse embryo in the establishment of anterior-posterior patterning.	EOMES FZD8	3.78e-04	15	67	2	15302604
Pubmed	Genetic variants in the prediction of rheumatoid arthritis.	HLA-DRB1 IRF5	4.31e-04	16	67	2	20439292
Pubmed	Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys.	SLC22A9 SLC22A10	4.31e-04	16	67	2	19679677
Pubmed	Pluripotency factors regulate definitive endoderm specification through eomesodermin.	EOMES FZD8	4.31e-04	16	67	2	21245162
Pubmed	Temporal requirements for ISL1 in sympathetic neuron proliferation, differentiation, and diversification.	RGMB PLXNA4 INSM2	4.51e-04	77	67	3	29445148
Pubmed	Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.	HLA-DRB1 IRF5	4.88e-04	17	67	2	21779181
Pubmed	Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.	RICTOR CBL	6.12e-04	19	67	2	31959764
Pubmed	The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation.	EOMES FZD8	6.12e-04	19	67	2	21822279
Pubmed	Tbx2 terminates shh/fgf signaling in the developing mouse limb bud by direct repression of gremlin1.	EOMES SPRY4	6.79e-04	20	67	2	23633963
Pubmed	Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis.	EOMES RICTOR	7.50e-04	21	67	2	23637172
Pubmed	Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency.	HLA-DRB1 AMBRA1	8.24e-04	22	67	2	20694011
Pubmed	Foxg1 confines Cajal-Retzius neuronogenesis and hippocampal morphogenesis to the dorsomedial pallium.	EOMES FZD8	9.82e-04	24	67	2	15858069
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FRMPD1 PCNX1 FAN1	1.02e-03	102	67	3	10231032
Pubmed	Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development.	FZD8 SPRY4	1.07e-03	25	67	2	21784065
Pubmed	FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells.	EOMES RICTOR	1.07e-03	25	67	2	28069738
Pubmed	Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring.	PLXNA4 RAC3	1.15e-03	26	67	2	39152101
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	JMJD6 AMBRA1 RICTOR HIC2 C11orf16 PRDM5 TEP1 RNF43	1.34e-03	1116	67	8	31753913
Pubmed	Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.	EOMES HLA-DRB1	1.44e-03	29	67	2	22190364
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	FZD8 EFNA3 PLXNA4	1.52e-03	117	67	3	17145500
Pubmed	Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.	EOMES RICTOR	1.54e-03	30	67	2	22056141
Pubmed	Correct patterning of the primitive streak requires the anterior visceral endoderm.	EOMES FZD8	1.54e-03	30	67	2	21445260
Pubmed	High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility.	PLXNA4 NOSTRIN	1.54e-03	30	67	2	19401682
Pubmed	The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.	PCNX1 RNF43	1.86e-03	33	67	2	19336002
Interaction	MYOF interactions	MEX3A SPRY4 RICTOR RAC2 RAC3	1.81e-05	102	64	5	int:MYOF
Interaction	STXBP3 interactions	RNF149 RICTOR STRA6 RAC2 RAC3	1.99e-05	104	64	5	int:STXBP3
Interaction	MAP3K11 interactions	CBL MAP4K2 RAC2 RAC3	3.95e-05	60	64	4	int:MAP3K11
Interaction	ZNF287 interactions	KLF15 ZNF770 PRDM5 ZNF445	3.95e-05	60	64	4	int:ZNF287
Interaction	ALDH3A2 interactions	RNF149 WSB2 ADCK2 CBL RNF43 RAC2 RAC3	4.94e-05	304	64	7	int:ALDH3A2
Interaction	ANKLE2 interactions	MEX3A RNF149 RNF43 RAC2 RAC3 FAN1	5.40e-05	210	64	6	int:ANKLE2
Interaction	ZDHHC8 interactions	RNF43 RAC2 RAC3	7.54e-05	26	64	3	int:ZDHHC8
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	KLF15 INSM2 ZNF770 ZNF683 HIC2 PRDM7 PRDM5 ZNF445	4.07e-04	718	46	8	28
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM7 PRDM5	8.41e-04	17	46	2	1197
GeneFamily	Rho family GTPases	RAC2 RAC3	1.17e-03	20	46	2	390
Coexpression	GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN	NAPSA B3GNT6 KLHDC1 RNF43 RAC2 PDCD1LG2	1.24e-05	200	67	6	M7150
CoexpressionAtlas	lung	NAPSA SHROOM4 HLA-DRB1 C11orf16 CD300C PCSK9	1.81e-05	182	64	6	lung
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	NAPSA CSGALNACT2 HLA-DRB1 RNF149 ZNF770 IRF5 NOSTRIN PDCD1LG2	1.87e-05	382	64	8	GSM538248_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3	NAPSA CSGALNACT2 HLA-DRB1 RNF149 ZNF770 IRF5 NOSTRIN PDCD1LG2	2.21e-05	391	64	8	GSM538249_500
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EOMES EFCAB6 ZNF683 RAC2 PDCD1LG2	2.95e-06	148	67	5	7cb4865a1e9522e24f9c14799568b67172bd99dc
ToppCell	Control-Endothelial_cells-Inflamed_endothelial_cells\|Control / group, cell type (main and fine annotations)	SHROOM4 SLC22A9 PKD1L1 SLC22A10 NOSTRIN	4.32e-06	160	67	5	958256e3d3836160763b82bb48f794087918d935
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA CSGALNACT2 RNF149 IRF5 TEP1	5.48e-06	168	67	5	00cff4698db14e03ca1d1b409e5ed1ad23b12615
ToppCell	droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA CSGALNACT2 RNF149 IRF5 TEP1	5.64e-06	169	67	5	90c00ab30e582b0e2a2be751e1fae9024cfb9ea6
ToppCell	wk_20-22-Hematologic-Myeloid-pre-pDC/DC5\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NAPSA HLA-DRB1 IRF5 LTB4R2 CD300C	7.06e-06	177	67	5	6de3c623f8595d7e3827df99b806bc9f1f15b3b7
ToppCell	PBMC-Mild\|PBMC / Compartment, Disease Groups and Clusters	CSGALNACT2 JMJD6 HLA-DRB1 RNF149 RICTOR	1.10e-05	194	67	5	d1366b169d14011194e61d16b6b0953349febc78
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HLA-DRB1 IRF5 CR1 CD300C RAC2	1.13e-05	195	67	5	4387e27d2288fb46a9ed110464542a4aea402358
ToppCell	5'-Adult-LymphNode-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAPSA HLA-DRB1 IRF5 CR1 RAC2	1.13e-05	195	67	5	e98217f9cf8c9574af66a1d8953101119c89c8a1
ToppCell	wk_08-11-Hematologic-Myeloid-Myelocyte-like\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	METTL25B CSGALNACT2 ZNF770 IRF5 RAC2	1.16e-05	196	67	5	4b88c96b737a747422674ad99c073b28e6febc7c
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CSGALNACT2 RNF149 PCNX1 CR1 RAC2	1.19e-05	197	67	5	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	RGMB MEX3A PLXNA4 HIC2 RAC3	1.27e-05	200	67	5	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor\|E18.5-samps / Age Group, Lineage, Cell class and subclass	NAPSA ADAMTSL1 EFCAB6 RNF43	3.57e-05	123	67	4	5f002f5180fe47fe57ab888b5f0319df99ab2c59
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	6.25e-05	142	67	4	39ada235a46f2202c093cf2336de224a5957ed1a
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EOMES ZNF683 RAC2 PDCD1LG2	7.93e-05	151	67	4	1525422afadff68a1525ced6d5db45fdea450678
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	8.13e-05	152	67	4	bfc7ef4ee26165d18ac4f475a9519e8d52453ba2
ToppCell	facs-Aorta-Heart-24m-Mesenchymal-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 LTB4R2 RAC2	8.13e-05	152	67	4	254f92d9e6c9c6404f3875dd54d655af87854b14
ToppCell	facs-Aorta-Heart-24m-Myeloid-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	8.13e-05	152	67	4	525d65c5c8e5580947367afdb1f6e68b49e9e5bb
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA KLHDC1 CD300C PDCD1LG2	8.99e-05	156	67	4	5d97755db872d51522f6412a93704f3c79a084cd
ToppCell	PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NAPSA IRF5 CBL RAC2	8.99e-05	156	67	4	166f7b1220eaf8e1149dde260dd85a094855c54f
ToppCell	PND07-28-samps-Myeloid-Granulocyte\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NAPSA IRF5 CBL RAC2	8.99e-05	156	67	4	5e1c5a7c9293b886920739cf766521df7f69726c
ToppCell	facs-MAT-Fat-18m-Lymphocytic-NK_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES ADCK2 RNF43 RAC2	9.22e-05	157	67	4	e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6
ToppCell	facs-Aorta-Heart-24m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	9.68e-05	159	67	4	443f6df4a88fa8755adcde4cc12575dff614ecb4
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l1-4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 RAC2	9.92e-05	160	67	4	6329b0f02f9509086e563c2ed762a8ec693883b5
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES NAPSA IRF5 RAC2	1.02e-04	161	67	4	16f77e7a5444d2f2b210362816cd7a07b9b42af6
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 CD300C	1.02e-04	161	67	4	787f91f906756ef570c0d02936c3cdfafb3f7454
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES NAPSA IRF5 RAC2	1.02e-04	161	67	4	f5821f551cf5c64c9f75cdb723492c87aac1ece0
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 CD300C	1.02e-04	161	67	4	3db97af49520dc8cbafb4454d8afd9d588160e89
ToppCell	droplet-Mammary_Gland-nan-21m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 CD300C	1.02e-04	161	67	4	f1d258c81bcf0f3c52bd20aa58faa9a5fd888168
ToppCell	facs-Pancreas-Exocrine-18m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES NAPSA IRF5 RAC2	1.02e-04	161	67	4	58a32a1033f379579697bda1bbf047a088e4a34f
ToppCell	Immune_cells-B_cell\|World / Lineage and Cell class	NAPSA IRF5 RAC2 PDCD1LG2	1.07e-04	163	67	4	3a02465de7c2f7cea227e289fb082a1fb6400301
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA CSGALNACT2 RNF149 IRF5	1.09e-04	164	67	4	cd0794f84dfd346807e2d803723718b7f22e9232
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHDC1 IRF5 PMEL RAC2	1.09e-04	164	67	4	b175258fb0885afd84d4a414c0ae441f880e8469
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA CSGALNACT2 RNF149 IRF5	1.09e-04	164	67	4	12251a49fd4af32d4edb58046245548c260cf04b
ToppCell	facs-MAT-Fat-3m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 CD300C	1.09e-04	164	67	4	b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHDC1 IRF5 PMEL RAC2	1.09e-04	164	67	4	875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHDC1 IRF5 PMEL RAC2	1.09e-04	164	67	4	8bcfc93220d7c99dddb32b7fa7fb9aec2a1c63fa
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	SHROOM4 SPRY4 PMEL LTB4R2	1.12e-04	165	67	4	ecaeb90a6bc27524ef6f2eefa72aec7315dbde3b
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 RAC2 PDCD1LG2	1.14e-04	166	67	4	8e5a262dc4f04c5fc75b9a7a907832a0d7877df0
ToppCell	droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 CD300C RAC2	1.14e-04	166	67	4	e01c720de6d4ca144c55378e023e718a64bf32f6
ToppCell	facs-GAT-Fat-24m-Myeloid-myeloid_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.17e-04	167	67	4	5d9ffbcb539d9c50cef9dd792ea11aa37dd2c1df
ToppCell	facs-Heart-LV-24m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CD300C RAC2 PDCD1LG2	1.17e-04	167	67	4	4a669eafde3582a451614ad304769b47aa1d9578
ToppCell	facs-GAT-Fat-24m-Myeloid\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.17e-04	167	67	4	c31e41fb76ba261ac546fac3cc2b8337e39bfa86
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT6 FZD8 PLXNA4 PMEL	1.17e-04	167	67	4	2812353ff66e76f10bd327ceb0e6b009502a5258
ToppCell	facs-Heart-LA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF43 RAC2 PDCD1LG2	1.17e-04	167	67	4	8ce8d93c79ac6a3f52252b4cec53378c362bfe0a
ToppCell	facs-Heart-LA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF43 RAC2 PDCD1LG2	1.17e-04	167	67	4	8340f7075d00dccb304cfd4c9b5711ca6dbf7cce
ToppCell	facs-Marrow-KLS-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT6 FZD8 PLXNA4 PMEL	1.17e-04	167	67	4	d15168f46c1599d9fc68a05a7b822c4b439f2987
ToppCell	facs-GAT-Fat-24m-Myeloid-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.17e-04	167	67	4	a04d1f2413fd24ad5e9cc67312220606157fecf3
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 CD300C RAC2	1.20e-04	168	67	4	84977db9d71e59208727885320cc18d80d064380
ToppCell	facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 TEP1 RAC2	1.20e-04	168	67	4	ba9ddd403ee6d6af2fe56dffbd419764bfb703e4
ToppCell	facs-Lung-3m-Hematologic-myeloid-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 TEP1 RAC2	1.20e-04	168	67	4	af4c35c0d3f030cef8397c35fa498a71112bb16b
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCLAF3 FZD8 ANKFY1 ETFDH	1.22e-04	169	67	4	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CD300C RAC2 PDCD1LG2	1.22e-04	169	67	4	ae85cef7ef8f761c19f4af2a23fe333641c38a92
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA CD300C RAC2 PDCD1LG2	1.22e-04	169	67	4	c01bc3f2f299109086ded83dc11e98559bf1940c
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	BCLAF3 FZD8 ANKFY1 ETFDH	1.22e-04	169	67	4	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	facs-SCAT-Fat-24m-Myeloid-myeloid_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.25e-04	170	67	4	13480e5f2de50425e42be0144b876e9aa4006a68
ToppCell	facs-SCAT-Fat-24m-Myeloid-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.25e-04	170	67	4	d22cd09a43a14045bb1181189fe8accf78fdde3b
ToppCell	facs-SCAT-Fat-24m-Myeloid\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 RAC2	1.25e-04	170	67	4	f9968d3735328a39157764343dd40f1ad8bf710d
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 TEP1 RAC2	1.28e-04	171	67	4	87cb65648c663e246f94cea1a5ed12e8e29ec629
ToppCell	facs-Lung-18m-Hematologic-myeloid\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 RAC2	1.28e-04	171	67	4	4ad28ecfde3d529a09b80be908c446bd5274518e
ToppCell	368C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SPRY4 PLXNA4 RICTOR RAC3	1.28e-04	171	67	4	714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell	droplet-Lung-21m-Hematologic-myeloid\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.28e-04	171	67	4	22ad6de44e1d3f72a3d78d46fd26a5743a4f84a5
ToppCell	droplet-Limb_Muscle-nan-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES RNF43 RAC2 PDCD1LG2	1.28e-04	171	67	4	4198e7fef1aaee3d85722094f3e444655d393e9e
ToppCell	droplet-Trachea-nan-3m-Myeloid-macrophage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	1.31e-04	172	67	4	f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0
ToppCell	droplet-Lung-nan-18m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 TEP1	1.31e-04	172	67	4	35d09640d5b04fa0bbb1b40d4b8f97da587a5046
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 TEP1 RAC2	1.31e-04	172	67	4	cabe7b4131d72da87d3caacd8cced3a4f2cbef53
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 TEP1 RAC2	1.31e-04	172	67	4	f3bbe3f069ad070778430d1a6cd9db0a76deb8de
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-DC2\|bone_marrow / Manually curated celltypes from each tissue	NAPSA HLA-DRB1 IRF5 CD300C	1.31e-04	172	67	4	64928cea7e5b60e4bc4af016454b0173ebcc07c7
ToppCell	droplet-Lung-nan-18m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 TEP1	1.31e-04	172	67	4	98cb64e2a768908105701a7a5b58f336036250fd
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.31e-04	172	67	4	a53c906539557594ef10368bc29aec4af063fd37
ToppCell	droplet-Limb_Muscle-nan-18m-Lymphocytic\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES RNF43 RAC2 PDCD1LG2	1.31e-04	172	67	4	a3bcf0d432d8fccce50248e8d0c7a4804d69bfee
ToppCell	droplet-Limb_Muscle-nan-18m-Lymphocytic-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EOMES RNF43 RAC2 PDCD1LG2	1.31e-04	172	67	4	976d27edd5608616830624907fe050fcd3551865
ToppCell	facs-Trachea-nan-24m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 RAC2 PDCD1LG2	1.34e-04	173	67	4	71c90c57225e452c73bf7bea46b454c472bf5f76
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.34e-04	173	67	4	9acad7ec70f713fe3db6cef7bbe3b183bf16ae67
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCLAF3 CSGALNACT2 ETFDH CD300C	1.37e-04	174	67	4	ff13a5c55d18b951315908f33cb47c7f9cb901bf
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RNF149 LTB4R2 CD300C RAC2	1.40e-04	175	67	4	e991ffa4d1d278a011592b9915cd35fe76db20cc
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAPSA HLA-DRB1 CR1 RAC2	1.40e-04	175	67	4	d544f24ee33783ed4afb4d7ec079a4484118bb15
ToppCell	droplet-Heart-HEART-1m-Hematologic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 TEP1 RAC2 RAC3	1.40e-04	175	67	4	43b9cfd7c47d57244565c641e57f3256b5900804
ToppCell	droplet-Heart-HEART-1m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 TEP1 RAC2 RAC3	1.40e-04	175	67	4	a2fed97cf8d28f9936fe791e5e8c43d2430330c9
ToppCell	droplet-Heart-HEART-1m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF5 TEP1 RAC2 RAC3	1.43e-04	176	67	4	1df640f88667e2dad30e65279d6d33bba75024c1
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA RNF149 IRF5 TEP1	1.43e-04	176	67	4	1bf8fed48bd224f09efe90a38233b1f01d7311fe
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA IRF5 TEP1 RAC2	1.43e-04	176	67	4	a85ad8b4815fde72edd5c900e882a0bc04033ea8
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DRB1 IRF5 CR1 RAC2	1.49e-04	178	67	4	2e51c1596022b7047994ee13c18375bad19a54a5
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.53e-04	179	67	4	66afd54428e6dcadc3e341faecfde42be4fb5905
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DRB1 IRF5 RAC2 PDCD1LG2	1.53e-04	179	67	4	1016af3d61a9276a792629f8b1a28a93038e29c1
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EOMES ZNF683 C11orf16 RAC2	1.53e-04	179	67	4	f7d3d37505893ae55065c89d957084602729decc
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.53e-04	179	67	4	fa58fa0901eadb170e3d2facb2a3d8c5e624329a
ToppCell	droplet-Lung-1m-Hematologic-myeloid\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 TEP1	1.53e-04	179	67	4	6d2458a887047b5c20389f08345ff5aac7c683e6
ToppCell	356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EOMES EFNA3 HLA-DRB1 ZNF683	1.56e-04	180	67	4	f24d4cbba4cb50fce3b3d9c4629aa856d9b05358
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF683 CR1 CD300C RAC2	1.56e-04	180	67	4	1c5515f29ead129bee3b4ca27799796956811a39
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DRB1 IRF5 CR1 RAC2	1.59e-04	181	67	4	e7d9910f6143055645b6f03b1018282e6c215f10
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EOMES NAPSA ZNF683 RAC2	1.59e-04	181	67	4	dd4126bf3c02e63866e2b3f2db81e3565f0e8c40
ToppCell	droplet-Lung-18m-Hematologic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NAPSA RNF149 IRF5 RAC2	1.59e-04	181	67	4	f6017f64ff236a9a7d2c4810aa2f350b5f02f8ad
ToppCell	18-Airway-Epithelial-Submucosal_gland_basal\|Airway / Age, Tissue, Lineage and Cell class	EFNA3 STRA6 RNF43 PDCD1LG2	1.59e-04	181	67	4	33938e6521712058312879f84f4ae381c2bfc379
ToppCell	11.5-Distal-Immune-Immune\|Distal / Age, Tissue, Lineage and Cell class	HLA-DRB1 IRF5 CD300C RAC2	1.59e-04	181	67	4	193ee02f547a218b2fc13e1174ea4cff4f8a3450
ToppCell	wk_15-18-Hematologic-Myeloid-pre-pDC/DC5\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	HLA-DRB1 IRF5 CD300C RAC2	1.63e-04	182	67	4	748401d2c84260a777001dd75b0182453185addc
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAPSA HLA-DRB1 CR1 RAC2	1.70e-04	184	67	4	a068ae741889d59937690c11e0bf405481402c25
ToppCell	droplet-Mammary_Gland-nan-3m-Lymphocytic-B_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 RAC2 PDCD1LG2	1.73e-04	185	67	4	bf4dbb5f139566750e50a81eb062ed8b9e5786c3
ToppCell	droplet-Mammary_Gland-nan-3m-Lymphocytic-B_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA IRF5 RAC2 PDCD1LG2	1.73e-04	185	67	4	3d035bb453a5942411da4eb8b3a1ca0961a089b2
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EOMES NAPSA ZNF683 RAC2	1.77e-04	186	67	4	e37e317e9770e35cb41137f51868d8b20ecd21d8
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NAPSA HLA-DRB1 CR1 RAC2	1.77e-04	186	67	4	b5e094850ac3785775393cd78a939b02339732b0
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; PC3; HT_HG-U133A	STK11 ANKFY1 PIDD1 PCNX1 HIC2 IRF5 STRA6	1.89e-06	198	67	7	4681_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A	METTL25B ANKFY1 EFNA3 FRMPD1 ADCK2 PCNX1	2.50e-05	197	67	6	4189_DN
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	EFNA3 PCNX1 HIC2 STRA6 MAP4K2 RAC2	2.50e-05	197	67	6	4831_UP
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	EFNA3 PCNX1 IRF5 STRA6 CBL MAP4K2	2.50e-05	197	67	6	6026_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	METTL25B ANKFY1 PIDD1 PMEL CBL RNF43	2.65e-05	199	67	6	2289_DN
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	STARD8 EFCAB6 FRMPD1 HRH4 ADCK2 CD300C	2.65e-05	199	67	6	3786_UP
Drug	B258	RAC2 RAC3	1.27e-04	6	67	2	CID000593690
Drug	DBMIB	JMJD6 ETFDH RAC2	1.91e-04	38	67	3	CID000034474
Drug	Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A	STK11 SPEG AMBRA1 ADCK2 TEP1	2.27e-04	187	67	5	7402_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; HL60; HT_HG-U133A	ANKFY1 PIDD1 PCNX1 CR1 CBL	2.44e-04	190	67	5	1343_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	FZD8 ANKFY1 PCNX1 TEP1 CBL	2.50e-04	191	67	5	4298_DN
Drug	Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	STK11 TTBK2 PCNX1 STRA6 TEP1	2.50e-04	191	67	5	6837_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	ADCK2 PCNX1 PMEL CR1 CBL	2.50e-04	191	67	5	2824_UP
Drug	Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A	STK11 FRMPD1 PCNX1 CR1 TEP1	2.62e-04	193	67	5	2275_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ANKFY1 EFNA3 PCNX1 CBL RAC3	2.62e-04	193	67	5	3624_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	EFNA3 JMJD6 PCNX1 HIC2 CBL	2.62e-04	193	67	5	5602_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	STK11 TTBK2 PIDD1 PCNX1 TEP1	2.68e-04	194	67	5	6833_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	STARD8 ADCK2 PCNX1 IRF5 RAC3	2.68e-04	194	67	5	5954_UP
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SPEG PIDD1 AMBRA1 CR1 MAP4K2	2.75e-04	195	67	5	3393_DN
Drug	Acacetin [480-44-4]; Up 200; 14uM; HL60; HT_HG-U133A	EFCAB6 JMJD6 PMEL CR1 RAC3	2.75e-04	195	67	5	2189_UP
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; PC3; HT_HG-U133A	STK11 ANKFY1 IRF5 CBL RNF43	2.75e-04	195	67	5	3719_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	EFNA3 JMJD6 AMBRA1 PCNX1 MAP4K2	2.75e-04	195	67	5	6648_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	STK11 EFNA3 FRMPD1 HRH4 C11orf16	2.81e-04	196	67	5	3571_UP
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	METTL25B FRMPD1 PIDD1 PCNX1 TEP1	2.81e-04	196	67	5	6305_UP
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	HIC2 PMEL STRA6 TEP1 CBL	2.81e-04	196	67	5	2847_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	METTL25B EFNA3 PIDD1 HIC2 TEP1	2.81e-04	196	67	5	3830_DN
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	PIDD1 PCNX1 HIC2 CBL RAC3	2.81e-04	196	67	5	4143_DN
Drug	Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A	STK11 FRMPD1 PIDD1 PCNX1 TEP1	2.81e-04	196	67	5	4958_UP
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	METTL25B PIDD1 HIC2 MAP4K2 RAC3	2.81e-04	196	67	5	5409_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	ANKFY1 EFNA3 AMBRA1 ADCK2 IRF5	2.81e-04	196	67	5	2628_DN
Drug	Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A	STK11 EFNA3 JMJD6 HIC2 C11orf16	2.81e-04	196	67	5	3579_UP
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	STK11 ANKFY1 AMBRA1 IRF5 RAC3	2.81e-04	196	67	5	6323_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	STK11 METTL25B ANKFY1 EFNA3 ADCK2	2.81e-04	196	67	5	2764_DN
Drug	1-phenylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	METTL25B STARD8 KLF15 AMBRA1 PCNX1	2.88e-04	197	67	5	22_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EFNA3 PCNX1 HIC2 MAP4K2 RAC3	2.88e-04	197	67	5	6060_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	TTBK2 PIDD1 HIC2 IRF5 TEP1	2.88e-04	197	67	5	6940_UP
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TTBK2 ADCK2 HIC2 PMEL RAC3	2.88e-04	197	67	5	3885_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A	TTBK2 EFNA3 ADCK2 PCNX1 HIC2	2.88e-04	197	67	5	5999_DN
Drug	Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A	FRMPD1 PIDD1 ADCK2 CR1 CBL	2.88e-04	197	67	5	5664_UP
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	FZD8 ANKFY1 EFNA3 SPEG PCNX1	2.88e-04	197	67	5	6758_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PCNX1 IRF5 TEP1 RNF43 MAP4K2	2.88e-04	197	67	5	3877_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	STK11 EFNA3 ADCK2 PCNX1 TEP1	2.88e-04	197	67	5	4730_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	METTL25B AMBRA1 PCNX1 C11orf16 CR1	2.88e-04	197	67	5	5840_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	EFNA3 PCNX1 STRA6 CBL MAP4K2	2.95e-04	198	67	5	6053_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A	JMJD6 PIDD1 PCNX1 HIC2 CD300C	2.95e-04	198	67	5	2294_UP
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	ANKFY1 EFNA3 JMJD6 ADCK2 HIC2	2.95e-04	198	67	5	7375_UP
Drug	Pipemidic acid [51940-44-4]; Up 200; 13.2uM; HL60; HT_HG-U133A	FZD8 EFNA3 ADCK2 PCNX1 CBL	2.95e-04	198	67	5	3093_UP
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	PIDD1 PCNX1 IRF5 TEP1 RNF43	2.95e-04	198	67	5	5259_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; HL60; HT_HG-U133A	STK11 METTL25B JMJD6 AMBRA1 RAC3	2.95e-04	198	67	5	3112_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A	TTBK2 METTL25B SPEG AMBRA1 MAP4K2	2.95e-04	198	67	5	2047_DN
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	STK11 EFCAB6 SPEG HIC2 CBL	2.95e-04	198	67	5	5615_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	CR1 CBL RNF43 RAC2 RAC3	2.95e-04	198	67	5	5214_UP
Drug	Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A	TTBK2 PIDD1 AMBRA1 PCNX1 HIC2	2.95e-04	198	67	5	1287_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ANKFY1 EFNA3 PCNX1 STRA6 CBL	2.95e-04	198	67	5	6043_DN
Drug	ondansetron	JMJD6 HRH4 RNF43	2.96e-04	44	67	3	CID000004595
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; HL60; HT_HG-U133A	STK11 ANKFY1 PIDD1 ADCK2 RAC3	3.02e-04	199	67	5	1863_UP
Drug	Bufexamac [2438-72-4]; Up 200; 18uM; PC3; HT_HG-U133A	FRMPD1 PIDD1 HIC2 CR1 RNF43	3.02e-04	199	67	5	5090_UP
Drug	Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A	EFNA3 PIDD1 PCNX1 TEP1 CBL	3.02e-04	199	67	5	7429_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A	PIDD1 AMBRA1 PCNX1 PMEL CR1	3.02e-04	199	67	5	2095_UP
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A	STARD8 PIDD1 PCNX1 TEP1 RAC2	3.02e-04	199	67	5	7450_UP
Drug	benserazide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	STARD8 KLF15 ADCK2 IRF5 RAC2	3.02e-04	199	67	5	641_UP
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	PIDD1 AMBRA1 ADCK2 RNF43 RAC3	3.02e-04	199	67	5	5988_DN
Drug	Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	STARD8 SPEG PMEL CBL RNF43	3.09e-04	200	67	5	3418_UP
Drug	Noscapine [128-62-1]; Up 200; 9.6uM; MCF7; HT_HG-U133A	TTBK2 ANKFY1 SPEG PIDD1 RNF43	3.09e-04	200	67	5	7204_UP
Disease	autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology)	RAC2 RAC3	1.43e-05	3	65	2	DOID:0080235 (implicated_via_orthology)
Disease	Diffuse Scleroderma	HLA-DRB1 IRF5	4.76e-05	5	65	2	C1258104
Disease	CREST Syndrome	HLA-DRB1 IRF5	7.13e-05	6	65	2	C0206138
Disease	Scleroderma, Limited	HLA-DRB1 IRF5	7.13e-05	6	65	2	C0748540
Disease	estrogen measurement	SLC22A9 SLC22A10	2.13e-04	10	65	2	EFO_0011007
Disease	ovarian neoplasm	STK11 JMJD6 SLC22A10 RNF43	2.22e-04	134	65	4	C0919267
Disease	Malignant neoplasm of ovary	STK11 JMJD6 SLC22A10 RNF43	2.42e-04	137	65	4	C1140680
Disease	Benign tumor of pancreas	STK11 RNF43	3.67e-04	13	65	2	C0347284
Disease	rheumatoid arthritis, COVID-19	EFNA3 HLA-DRB1 IRF5	3.86e-04	64	65	3	EFO_0000685, MONDO_0100096
Disease	employment status	PLXNA4 KLF15	4.93e-04	15	65	2	EFO_0005241
Disease	Pancreatic carcinoma	STK11 RNF43	7.98e-04	19	65	2	C0235974
Disease	Juvenile Myelomonocytic Leukemia	CBL RAC2	7.98e-04	19	65	2	C0349639
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	TEP1 RNF43	7.98e-04	19	65	2	DOID:4928 (is_marker_for)
Disease	alcohol use disorder (implicated_via_orthology)	ZNF683 MAP4K2 RAC2 RAC3	9.14e-04	195	65	4	DOID:1574 (implicated_via_orthology)
Disease	fetal hemoglobin measurement	OR51B6 PRDM5	9.77e-04	21	65	2	EFO_0004576
Disease	fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement	ETFDH MAP4K2	1.39e-03	25	65	2	EFO_0004465, EFO_0004466, EFO_0004469
Disease	colorectal adenocarcinoma (is_marker_for)	RICTOR STRA6	1.62e-03	27	65	2	DOID:0050861 (is_marker_for)
Disease	QRS-T angle	ADAMTSL1 SPEG PCNX1	1.67e-03	106	65	3	EFO_0020097
Disease	Neoplasm of uncertain or unknown behavior of ovary	STK11 RNF43	1.87e-03	29	65	2	C0496920
Disease	multiple sclerosis	EOMES ADAMTSL1 CSGALNACT2 HLA-DRB1 SPRY4 IRF5	1.96e-03	594	65	6	MONDO_0005301
Disease	Ovarian Carcinoma	STK11 RNF43	2.00e-03	30	65	2	C0029925

Protein segments in the cluster

Peptide	Gene	Start	Entry
LCNRPLWLKFHRHQT	EOMES	271	O95936
QFSKLHVRVTPHPWT	ADCK2	166	Q7Z695
PHPWTHTERFLRQAF	ADCK2	176	Q7Z695
HVQKLPWDHVPCLRR	C1orf167	91	Q5SNV9
LIGHRRTPWCVTFHP	AMBRA1	91	Q9C0C7
KHPTHWNRQCTFILR	CC2D2B	1331	Q6DHV5
EKEHRTLNKFWCRPP	CD300C	46	Q08708
RTHPTWLLHIFIPFC	PDCD1LG2	216	Q9BQ51
ENVRAKWFPEVRHHC	RAC2	91	P15153
KWFPEVRHHCPSTPI	RAC2	96	P15153
KWYPEVRHHCPHTPI	RAC3	96	P60763
PRHSNWLRFVHEAPS	PRDM5	76	Q9NQX1
CPLRIHAAVTWIHPV	MAP4K2	481	Q12851
HRNKWGETPLHTACR	ANKFY1	486	Q9P2R3
QGHKRWCLFPTSTPR	JMJD6	201	Q6NYC1
PIIHRWRETDFFPCS	ADAMTSL1	296	Q8N6G6
LPQVRKQLPWHCFSH	PCNX1	1311	Q96RV3
TATFHRCAKDPWRLP	PCSK9	61	Q8NBP7
DPHVRHTWKSNCLPL	PLXNA4	1731	Q9HCM2
PIVVRLHWFPYCRSH	OR51B6	156	Q9H340
SVLFPIWFKCHRPRH	MRGPRD	126	Q8TDS7
SPHHVVRWVDPTALC	METTL25B	221	Q96FB5
KLFCIPWRHATRHGP	IRF5	41	Q13568
SCPANLASHRRWHKP	INSM2	301	Q96T92
DAVRHSRKHLWPVVP	RICTOR	991	Q6R327
HNRPRWEATHNCPCL	FZD8	556	Q9H461
PFREFQRWKHHPSIR	ETFDH	336	Q16134
QRWKHHPSIRPTLEG	ETFDH	341	Q16134
TPVPGLFHLWHEKRC	CSGALNACT2	476	Q8N6G5
WKHRSLSPVPRNAEH	BCLAF3	11	A2AJT9
KRWECNRPHAPHSPI	EFNA3	106	P52797
DRWDPPLAKCTSRTH	CR1	1956	P17927
IIPDWLRSHPHTRKF	EFCAB6	6	Q5THR3
HPPEKCTWHFTESRS	FRMPD1	1446	Q5SYB0
DTRPRFLWQPKRECH	HLA-DRB1	31	P01911
THLPKTRPRLWHTAC	KLHDC1	291	Q8N7A1
HLRRHTGEKPFACTW	KLF15	341	Q9UIH9
PWKSFRQALHEVHPI	CBL	201	P22681
RHCRHFPLLWDAPAK	B3GNT6	96	Q6ZMB0
QQARHLRWAHPPSKA	PKD1L1	2251	Q8TDX9
EAPQRLWAHCQVPHF	PIDD1	431	Q9HB75
HPCSNSIFRWREKEH	NOSTRIN	381	Q8IVI9
RDWNRLKNHPSLRCH	FAN1	636	Q9Y2M0
RQHEKTHWLTRPFPC	HIC2	521	Q96JB3
LWKRDHLSRCQSHPG	HRH4	201	Q9H3N8
EALHPRKERWHIFPS	RGMB	396	Q6NW40
PTPARCDQDVTHHWI	SPRY4	76	Q9C004
HLWRDRVCQLCHPSP	LTB4R2	161	Q9NPC1
EKCRRFVHPQWQLLH	SLC22A9	86	Q8IVM8
EKCRRFVHPQWQLLH	SLC22A10	86	Q63ZE4
RSIHVPHAVWPFQVK	PRDM7	416	Q9NQW5
RNCVDPWLHQHRTCP	RNF43	296	Q68DV7
RNAPVSRPHSWHVAK	SHROOM4	91	Q9ULL8
RQIRQHSWFRKKHPP	STK11	301	Q15831
PHSSSHWLRLPRIFC	PMEL	631	P40967
CRKLRWHSFQNSHRP	STARD8	491	Q92502
LHRSPHPSRQAIFCW	STRA6	406	Q9BX79
HKSFTREHPRPLHWA	C11orf16	226	Q9NQ32
PQHSSHWCPEREKVK	C11orf40	26	Q8WZ69
PCKHIFHRICIDPWL	RNF149	286	Q8NC42
PVLIHSFPACHRDWV	TEP1	2096	Q99973
VHPWSRPSLQDCLAH	SPEG	3201	Q15772
WRVHQPGCKPLSTFR	MEX3A	321	A1L020
SHIPLRPKHWFQLCR	SPDYE3	476	A6NKU9
HKPCVPAVSRTDHIW	TTBK2	491	Q6IQ55
PHWKRHQLTHFKERP	ZNF770	666	Q6IQ21
HQRIHSTERPFKCQW	ZNF445	886	P59923
WARHHPQVPDVSCLV	WSB2	111	Q9NYS7
VHTGERPHKCSIPWV	ZNF683	371	Q8IZ20
PRAWECHLRRVHNLT	nan	41	Q6ZRX8
FFSVPCWLHHRFDPK	NAPSA	111	O96009